Key facts
- Bioeutectics’s last known valuation is $13.0M (May 2025).
- It has raised $4.8M; the latest was Accelerator/Incubator in Oct 2025.
- Notable investors include MassChallenge, SOSV, Endless Frontier Labs, IndieBio, Atento Capital — 16 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 16 names
- ·Watchlist + deal alerts for Bioeutectics
- ·The full record, as it builds
Funding rounds
No funding rounds for Bioeutectics are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Bioeutectics
Developer of natural and sustainable solvents designed to replace petrochemicals in industrial processes. The company offers bio-sourced eutectic solvents made from natural acids, amino acids, alcohols, and sugars, allowing the personal care, food ingredients, agrotech, and greentech industries to adopt environmentally friendly, biodegradable alternatives, and aims to replace petrochemical solvents with bio-solvents, enabling clients to access sustainable products and enhance functionality.
- Sector
- Materials and Resources
- HQ
- Tulsa, OK, United States
- Founded
- 2021
- Employees
- 14
- Website
- bioeutectics.com/
- Ownership
- Privately Held (backing)
Bioeutectics doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Bioeutectics shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Bioeutectics in its N-PORT filings yet. We sweep new filings monthly.